SANDOZ GLICLAZIDE MR
SANDOZ GLICLAZIDE MR
Approved
DIN Number
02461323
Drug Class
Human
Market Date
Jun 2, 2017
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02461323
AIG Number0119934002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BB09 GLICLAZIDE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification68:20.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
GLICLAZIDEActive
Strength: 30 MG
Monograph: GLICLAZIDE